(PharmaNewsWire.Com, February 07, 2020 ) Healthcare chatbots market is mainly driven by rising Internet connectivity and smart device adoption, company initiatives to boost the healthcare chatbots, and the need for virtual assistance.
The global healthcare chatbots market is projected to reach USD 314.3 million by 2023 from USD 122.0 million by 2018, at a CAGR of 20.8% from 2018 to 2023.
Concerns regarding data privacy pose a major challenge for the market. Chatbots are used for various applications in healthcare industry. Chatbots use software that applies AI to process language from interactions between humans and virtual assistants. As chatbots are actively being implemented, data security & privacy is one of the major challenges faced by the market. Patient data contain personal, private, or confidential information and requires strict safeguards to prevent its misuse. Patient data is protected under federal laws in many countries, and any breaches or failures to maintain its integrity can result in legal and financial penalties. Since chatbots used for patient care require access to multiple data sets, it is mandatory for AI-based tools such as chatbots to adhere to all data security protocols implemented by government and regulatory authorities. This is a very difficult task as most AI-based platforms are consolidated and require extensive computing power owing to which patient data, or part of it, can be required to reside in a vendor’s data set.
At present, chatbots are adopted among the developed countries such as North and Europe, and is yet to witness widespread adoption in emerging countries, where doctors and other healthcare providers are still reluctant to adopt advanced healthcare solutions. Data privacy concerns and a lack of sufficiently skilled personnel to develop healthcare chatbots also serve to affect market growth to a certain extent.
Growing usage of healthcare chatbots by clinicians and hospitals to increase their patient engagement rate, are driving the growth of the healthcare chatbots market.
Based on component, the healthcare chatbots market is segmented into software and services. The software segment is expected to account for a larger share in 2018 as compared to the services segment. Enhanced technological features in chatbot software, such as Natural Language Processing (NLP), multilingual capabilities, interference engine, cloud-based deployment, Application Programming Interface (API), mobile platform compatibility, and single point of search is propelling the growth of the software segment.
Geographical Region Covered
Europe is expected to lead the healthcare chatbots market, followed by North America. However, North America is expected to register the highest CAGR during the forecast period. The high growth in North America can be attributed to the growing number of therapy chatbots, rising adoption of smart devices, and growth in venture capital investments to develop advanced chatbots.
The healthcare chatbots market is marked by the presence of several established as well as emerging players. Prominent players offering healthcare chatbots are Your.MD (UK), HealthTap, Inc. (US), Sensely, Inc. (US), Buoy Health, Inc. (US), Infermedica (Poland), Babylon Healthcare Service Limited (UK), Baidu, Inc. (China), Ada Digital Health Ltd. (Germany), PACT Care BV (Netherlands), Woebot Labs, Inc. (US), and GYANT.Com, Inc. (US).
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
